The approach taken in this study therefore enabled the identification of a large variety of mutations, particularly in exon 17, which provides a sound understanding of the heterogeneity in KIT mutations in this late-line GIST setting. This evidence concerns the gene KIT and gastrointestinal stromal tumor.